Elevated ghrelin plasma levels in patients with polycystic ovary syndrome

被引:54
作者
Wasko, R
Komarowska, H
Warenik-Szymankiewicz, A
Sowinski, J
机构
[1] Poznan Univ Med Sci, Dept Endocrinol & Metab, PL-60355 Poznan, Poland
[2] Poznan Univ Med Sci, Dept Gynecol Endocrinol, Poznan, Poland
关键词
women; insulin; obesity; androgens; growth hormone; insulin-like growth factor I axis;
D O I
10.1055/s-2004-814341
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Polycystic ovary syndrome is a common endocrine disorder in women, It is associated with hirsuitism, obesity, insulin resistance, abnormality in the growth hormone/insulin-like growth factor 1 (IGF-1) axis and polycystic ovaries. The etiology of PCOS has not been clarified. Ghrelin is an endogenous ligand of the growth hormone secretagogue receptor. It is mainly secreted by stomach cells but has also been shown to be present in hypothalamus, pituitary, pancreas and gonads. Ghrelin is a regulator of energy homeostasis and GH secretion. The influence of ghrelin on insulin secretion and gonadal function is known. Since ghrelin may play an important role in pathophysiology of PCOS, we studied ghrelin levels in a group of 52 women with PCOS and in 16 women in a control group. Plasma levels of insulin, total testosterone, SHBG, LH, and FSH were also measured. In conclusion, PCOS women have higher ghrelin levels than controls. Ghrelin negatively correlates with BMI and insulin levels in PCOS group. A relation between ghrelin and SHBG was observed. Our data suggest that ghrelin could be the possible link in PCOS etiology.
引用
收藏
页码:170 / 173
页数:4
相关论文
共 34 条
[1]  
Ariayasu H, 2001, P 83 ANN M END SOC D, P336
[2]   Preliminary evidence that Ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans [J].
Arvat, E ;
Di Vito, L ;
Broglio, F ;
Papotti, M ;
Muccioli, G ;
Dieguez, C ;
Casanueva, FF ;
Deghenghi, R ;
Camanni, F ;
Ghigo, E .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2000, 23 (08) :493-495
[3]   Expression and homologous regulation of GH secretagogue receptor mRNA in rat adrenal gland [J].
Barreiro, ML ;
Pinilla, L ;
Aguilar, E ;
Tena-Sempere, M .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2002, 147 (05) :677-688
[4]   Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans [J].
Date, Y ;
Kojima, M ;
Hosoda, H ;
Sawaguchi, A ;
Mondal, MS ;
Suganuma, T ;
Matsukura, S ;
Kangawa, K ;
Nakazato, M .
ENDOCRINOLOGY, 2000, 141 (11) :4255-4261
[5]   Ghrelin is present in pancreatic α-cells of humans and rats and stimulates insulin secretion [J].
Date, Y ;
Nakazato, M ;
Hashiguchi, S ;
Dezaki, K ;
Mondal, MS ;
Hosoda, H ;
Kojima, M ;
Kangawa, K ;
Arima, T ;
Matsuo, H ;
Yada, T ;
Matsukura, S .
DIABETES, 2002, 51 (01) :124-129
[6]   A-like cells in the rat stomach contain ghrelin and do not operate under gastrin control [J].
de la Cour, CD ;
Björkqvist, M ;
Sandvik, AK ;
Bakke, I ;
Zhao, CM ;
Chen, D ;
Håkanson, R .
REGULATORY PEPTIDES, 2001, 99 (2-3) :141-150
[7]   Insulin action in thee polycystic ovary syndrome [J].
Dunaif, A .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1999, 28 (02) :341-+
[8]   Insulin resistance and the polycystic ovary syndrome: Mechanism and implications for pathogenesis [J].
Dunaif, A .
ENDOCRINE REVIEWS, 1997, 18 (06) :774-800
[9]  
EGIDO EM, 2001, DIABETOLOGIA S1, V44, pA135
[10]   MEDICAL PROGRESS - POLYCYSTIC-OVARY-SYNDROME [J].
FRANKS, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (13) :853-861